Immatics N.V.

Overview

Compare with another stock.

• TickerIMTX on Nasdaq¹
• IndustryBiological Products, (No Diagnostic Substances)¹
• HeadquartersP7¹
• Incorporated inNetherlands³
• Business addressPaul Ehrlich-Strasse 15, Tubingen, 2M 72076³
• Filer categoryAccelerated filer³

See how the biggest companies compare on our leaderboards

We were incorporated as a Dutch private limited liability company ( besloten vennootschap met beperkte aansprakelijkheid ) under the name Immatics B.V. on March 10, 2020 solely for the purpose of effectuating the business combination (the “ARYA Merger”) between us, ARYA Sciences Acquisition Corp., a Cayman Islands exempted company (“ARYA”), Immatics Biotechnologies GmbH, a German limited liability company, Immatics Merger Sub 1, a Cayman Islands exempted company, and Immatics Merger Sub 2, a Cayman Islands exempted company. Upon the closing of the ARYA Merger on July 1, 2020, we converted into a Dutch public limited liability company ( naamloze vennootschap ) and changed our name to Immatics N.V.⁴ From its latest annual report

Corporate structure

Immatics N.V. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Immatics N.V. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Leadership

Who has led Immatics N.V., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerJasuja Harpreet Singh Mar 18, 2026 to now¹⁰
• Chief financial officerVenkat Ramanan Mar 18, 2026 to now¹¹
• Chief operating officerSteffen Martin Walter Mar 18, 2026 to now¹²

Former names

• Immatics B.V.Apr 16, 2020 to Jul 8, 2020³

Timeline

1. Mar 18, 2026New chief executive Jasuja Harpreet Singh becomes CEO¹⁰

Calendar

Coming up

1. Nov 16, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.49) a share, on Nov 17, 2025.²⁸

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

177 filings to the SEC since October 2021: 6 annual reports, 31 insider forms, 40 large holders, 100 other. The latest 20:

1. Aug 27, 20264 EDGAR
2. Aug 27, 2026SCHEDULE 13D/A EDGAR
3. Aug 26, 20266-K EDGAR
4. Aug 25, 2026424B2 EDGAR
5. Aug 18, 20266-K EDGAR
6. Aug 18, 20264 EDGAR
7. Aug 14, 2026SCHEDULE 13G/A EDGAR
8. Jul 29, 20263 EDGAR
9. Jun 25, 2026S-8 EDGAR
10. Jun 18, 20264 EDGAR
11. Jun 18, 20264 EDGAR
12. Jun 18, 20264 EDGAR
13. Jun 18, 20264 EDGAR
14. Jun 18, 20264 EDGAR
15. Jun 18, 20264 EDGAR
16. Jun 18, 20264 EDGAR
17. Jun 18, 20264 EDGAR
18. Jun 18, 20264 EDGAR
19. Jun 18, 20266-K EDGAR
20. Jun 2, 20266-K EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• PERCEPTIVE ADVISORS LLCSCHEDULE 13D/A, 3 filings Jun 6, 2024 to Aug 27, 2026²⁹
• BAKER BROS. ADVISORS LPSCHEDULE 13G/A, 7 filings Feb 14, 2022 to Aug 14, 2026³⁰
• RTW INVESTMENTS, LPSCHEDULE 13G/A, 5 filings Nov 14, 2024 to May 15, 2026³¹
• T. Rowe Price Investment Management, Inc.SCHEDULE 13G/A, 5 filings Nov 14, 2024 to May 15, 2026³²
• Toronto-Dominion BankSCHEDULE 13G, 1 filing May 15, 2026³³
• Vestal Point Capital, LPSCHEDULE 13G/A, 2 filings Feb 14, 2025 to May 15, 2026³⁴
• MONTANOVA CAPITAL, LLCSCHEDULE 13G/A, 4 filings Feb 11, 2025 to Feb 13, 2026³⁵
• Wellington Management CompanySCHEDULE 13G/A, 5 filings Feb 7, 2023 to Aug 12, 2025³⁶
• ARYA SCIENCES HOLDINGSSC 13G/A, 1 filing Jun 6, 2024³⁷
• Kg AthosSC 13G/A, 3 filings Aug 16, 2023 to Feb 7, 2024³⁸
• Nantahala Capital Management, LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023³⁹
• dievini Hopp BioTech holding GmbH & Co KGSC 13G/A, 2 filings Feb 11, 2022 to Feb 10, 2023⁴⁰

SEC filer profile

How Immatics N.V. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARImmatics N.V.¹
• CIK0001809196
• Filer statusAccelerated filer not an emerging growth company; not a shell company⁴
• Incorporated inNetherlands⁴
• Fiscal year endsDecember 31¹
• Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business addressPaul Ehrlich-Strasse 15, Tubingen, 2M 72076¹
• Phone49 7071 5397 700¹
• Shares outstanding134,071,432 shares as of Dec 31, 2025⁴
• AuditorPricewaterhouseCoopers GmbH, Stuttgart, Germany PCAOB ID 1275; it also attests to the company’s internal control over financial reporting⁴
• On EDGAR sinceApr 16, 2020¹
• Filings241 in all: 6-K (93), 3 (20), SCHEDULE 13G/A (18), 4 (11), SC 13G/A (11), 424B3 (9), CORRESP (9), UPLOAD (9)¹
  All 30 form types

  SC 13G (8), 20-F (7), EFFECT (7), 424B5 (6), S-8 (5), F-4/A (4), 424B2 (3), F-3 (3), SCHEDULE 13G (3), 6-K/A (2), POS AM (2), 20-F/A (1), 25-NSE (1), 8-A12B (1), CERT (1), F-1 (1), F-1/A (1), F-3ASR (1), F-4 (1), SC 13D (1), SC 13D/A (1), SCHEDULE 13D/A (1)

• Latest filingsAnnual report (20-F) Mar 5, 2026

Securities registered for trading

From the cover page of the 20-F filed Mar 5, 2026 (Section 12(b) of the Exchange Act).⁴